Abbott Laboratories (WBO:ABT)
€ 108.8 -0.92 (-0.84%) Market Cap: 190.09 Bil Enterprise Value: 197.21 Bil PE Ratio: 34.45 PB Ratio: 4.94 GF Score: 92/100

Abbott Laboratories at UBS Global Healthcare Conference Transcript

May 21, 2019 / 03:00PM GMT
Release Date Price: €68.5 (+1.09%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Thanks, everybody, for joining us for our next session. I'm Matt Taylor, the U.S. medical supplies and devices analyst here at UBS. And we're really pleased to be joined by management from Abbott Laboratories. So with me onstage here is Brian Yoor, the EVP and President of Finance and Chief Financial Officer of Abbott. He's been in that position since February 2017. He previously served as SVP Finance and has been in Abbott since August 1997, so long tenure for the entire team here.

So Brian, to start out, we're going to do a fireside chat, but I want to give you a chance to talk about Abbott's diversified growth model and how that's helping you to deliver top tier organic growth here in the medical device space. So let's start with that one, then we'll get into some questions.

Brian B. Yoor
Abbott Laboratories - Executive VP of Finance & CFO

All right, sounds good, Matt. Thanks for having me here today. As we talk about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot